期刊
THROMBOSIS RESEARCH
卷 163, 期 -, 页码 105-116出版社
PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.thromres.2018.01.039
关键词
IFN; Endothelial cells; Angiogenesis; Blood haemostasis; Fibrinolysis
Introduction: Interferon (IFN)-alpha and IFN-ss approved for treatment of chronic hepatitis C viral infection and multiple sclerosis respectively have been linked to thrombotic microangiopathy (TMA) affecting renal function. Since the molecular mechanisms underlying this severe complication remain largely unclear, we aimed to investigate whether IFN affects directly in vitro endothelial cell functions associated with angiogenesis and blood haemostasis, as well as endothelial cell-derived vasodilators of nitric oxide (NO) and prostacyclin. Methods: Proliferation and survival of human umbilical vein endothelial cells (HUVECs) were measured by BrdU incorporation and alamarBlue assays. Angiogenesis was evaluated in co-cultures of HUVECs and human dermal fibroblasts. Fibrinolysis molecules were measured with ELISA. NO and prostacyclin were measured using a fluorescent NO-specific probe and a competitive enzyme immunoassay, respectively. Results: HUVEC proliferation was dose-dependently inhibited by IFN-ss 1a and IFN-ss 1b, but not by IFN-alpha 2a and IFN-alpha 2b. Consistently, IFN-ss 1a and IFN-ss 1b also reduced survival of HUVECs, but this again was not observed with IFN-alpha. However, both IFN subtypes inhibited VEGF-induced development of capillary-like structures, but the effect of IFN-alpha was less potent than IFN-ss. In addition, both IFN subtypes upregulated interferon inducible protein 10 production from treated co-cultures while suppressing angiogenesis. Furthermore, intracellular NO generation was reduced by IFN-alpha 2a and IFN-ss 1a, whereas prostacyclin release from HUVECs was not affected by IFN. Importantly, both IFN-ss 1a- and IFN-ss 1b-treated HUVECs showed a marked reduction in urokinase-type plasminogen activator release and a much greater secretion of plasminogen activator inhibitor-1 than tissue-type plasminogen activator compared with untreated cells, suggesting decreased fibrinolytic activity. IFN-alpha, however was less effective in modulating the fibrinolysis system. Conclusions: We demonstrate the detrimental effects of IFN on endothelial cell functions mediated with angiogenesis and fibrinolysis, which could potentially cause the loss of physiological endothelium thromboresistance and facilitate the development of vascular complications in a clinical setting. Mechanistically, our findings have implications for understanding how IFN therapy can foster the development of TMA.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据